CPL @1097 (79.3%) on 19-jan-2018 [ "_ 's oncology pipeline" "major pharmaceutical companies including _" "industrial placement at _" "It is marketed by _" "unrestricted grant from _" "_ 's drug discovery programs" "honoraria received from _" "pharmaceutical company called _" "preclinical development at _" "incorporated subsidiary of _" "initial due diligence into _" "unrestricted research grants from _" "honoraria from _" "It is manufactured by _" "_ 's new treatment" "quick guide is supported by _" "pharmaceutical companies including _" "global business development at _" "_ has exclusive worldwide rights" "_ 's Erbitux" "_ 's patent portfolio" "educational grants from _" "collaboration agreement with _" "market players covered are _" "players covered are _" "_ completes enrollment" "worldwide agreement with _" ] using merck_serono
OE @829 (100.0%) on 08-apr-2014 [ ] using merck_serono
SEAL @214 (99.9%) on 22-feb-2011 [ 12345678910 ] using merck_serono